Dr. Bing Hou, Executive Director of Drug Discovery at Antengene, is in charge of the discovery and translational study of innovative anti-cancer drugs. He has published research articles in top journals, such as Nature, Science Advances and Circulation Research. His co-first-authored Nature article published in 2014 was cited by both the Nobel Prize recipient and the official website of the Nobel Prize. Approximately thirty patent applications have been submitted by him in response to unmet medical needs for novel anti-cancer drugs. As inventor and project leader, he has advanced multiple drugs into clinical trials which benefit patients globally.